Lepu Medical Technology (Beijing) Co., Ltd. Class A

Lepu Medical Technology (Beijing) Co., Ltd. Class A

SSZSE:300003
12.07
CNY
+0.05
(+0.42%)
0.34EPS
32.65P/E
21.49BMarket Cap
Apr 28Next Earn
Lepu Medical Technology (Beijing) Co., Ltd. Class A
SZSE:300003
(Shenzhen Stock Exchange)

Recent

price

12.07

P/E

ratio

32.65

div

yld

2.77%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.47
0.57
0.63
0.8
1.03
1.71
2
2.55
3.57
4.4
4.52
5.95
5.89
4.29
3.3
3.52
3.35
Revenue per Share
0.25
0.29
0.25
0.22
0.26
0.32
0.39
0.51
0.68
0.97
1.01
0.96
1.22
0.68
0.13
0.52
0.36
Basic EPS, GAAP
0.14
0.1
0.1
0.14
0.14
0.17
0.33
0.11
0.24
0.81
0.84
1.16
1.05
0.08
0.04
0.47
- -
Free Cash Flow per Basic Share
0.05
0.14
0.09
0.09
0.07
0.09
0.13
0.16
0.27
0.36
0.34
0.33
0.35
0.41
0.54
0.37
0.33
Dividend per Share
1.27
1.44
1.61
1.74
1.94
2.96
3.17
3.61
3.56
4.2
5.47
6.36
8.05
8.5
8.08
8.74
8.89
Book Value per Share
1.15
1.3
1.45
1.33
1.36
1.48
1.58
1.53
1.44
1.55
2.88
3.37
5.03
5.21
4.54
5.1
5.16
Tangible Book Value per Share
1,624
1,624
1,624
1,624
1,624
1,624
1,736
1,779
1,782
1,770
1,777
1,792
1,802
1,862
1,848
1,843
1,843
Basic Weighted Avg Shares
770
920
1,016
1,303
1,669
2,769
3,468
4,538
6,356
7,796
8,039
10,660
10,609
7,980
6,103
6,483
6,171
Sales/Revenue/Turnover
58.31
55.5
43.43
31.94
31.04
26.06
27.41
29.21
28.23
29
27.04
25.36
26.95
23.12
11.75
23.73
17.73
Operating Margin (%)
17
24
35
51
67
132
167
206
231
284
388
449
488
514
560
639
- -
Depreciation Expense
410
473
403
362
423
521
679
899
1,219
1,725
1,802
1,719
2,204
1,258
247
962
658
Net Income, GAAP
13.12
12.86
15.94
15.12
15.73
14.97
16.19
16.88
14.86
16.45
14.81
17.04
14
16.86
12.61
16.21
10.4
Effective Tax Rate (%)
53.3
51.44
39.7
27.75
25.36
18.81
19.59
19.81
19.17
22.13
22.42
16.13
20.77
15.77
4.05
14.84
10.67
Profit Margin (%)
1,424
1,581
1,746
1,508
1,198
1,812
2,108
1,942
622
524
1,756
4,815
5,426
5,567
4,824
5,032
5,083
Working Capital
- -
- -
- -
- -
- -
310
1,324
2,384
3,219
2,458
2,434
4,008
2,401
3,373
3,876
3,135
3,864
LT Debt
2,066
2,342
2,618
2,894
3,293
5,339
6,013
7,027
6,576
8,005
10,537
12,274
16,372
17,498
16,740
17,760
17,786
Total Equity
20.98
21.05
15.72
12.96
13.6
11.89
10.18
10.09
10.39
12.67
12.55
10.75
11.86
5.94
0.99
4.39
2.62
Return on Invested Capital (%)
21.31
21.47
15.3
12.95
12.31
9.91
9.49
9.44
12.01
15.42
13.37
11.17
12.29
6.34
2.02
4.51
3.92
Return on Capital (%)
21.52
21.47
16.28
13.3
14.18
13.11
13.14
15.03
19.07
24.95
20.76
16.11
16.56
8.09
1.58
6.14
4.09
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
2,222
2,513
2,412
LT Borrowings
3,209
3,596
3,611
LT Finance Leases
219
246
253
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,843
1,843
1,843
Market Capitalization
29,863
21,845
21,494

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
9,233
9,554
9,332
Cash, Cash Equivalents & STI
3,990
4,410
4,056
Accounts Receivable, Net
2,241
2,342
2,359
Inventories
1,944
1,952
1,990
Total Current Liabilities
3,881
4,181
4,249
Payables & Accruals
- -
- -
- -
ST Debt
2,222
2,513
2,412
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.5%
11.7%
6.09%
Free Cash Flow
134.13%
188.5%
1,052.51%
Net Income, GAAP
33.42%
37.98%
289.57%
Sales/Revenue/Turnover
11.2%
-1.99%
6.22%
Total Cash Common Dividend
20.68%
5%
-31.22%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,922
1,462
1,402
1,318
6,103
2025
1,736
1,633
- -
1,544
6,483
2026
1,672
1,542
1,413
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.26
0.12
0.06
-0.3
0.13
2025
0.21
0.17
- -
-0.01
0.52
2026
0.13
0.14
0.1
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.35
0.16
0.01
0.54
2025
0.03
0.15
- -
0.02
0.37
2026
0.08
0.18
0.06
- -
- -
Business
Lepu Medical Technology (Beijing) Co., Ltd. specializes in the development, manufacturing, and marketing of high-tech medical devices and equipment with a focus on cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics, and general surgery. Its product portfolio includes coronary stents, balloon catheters, guide wires, introducer sheaths, fractional flow reserve systems, mechanical heart valves, pacemakers, electrophysiology catheters, digital subtraction angiography (DSA) systems, surgical staplers, ultrasound systems, hemodialysis products, home medical devices such as oxygen generators and nebulizers, oncology diagnostics, orthopedic products, and related accessories. The company also markets active pharmaceutical ingredients and formulations for cardiovascular diseases, oncology, anti-infectives, and the central nervous system. Lepu serves healthcare providers globally with operations that extend beyond China. Founded in 1999 and headquartered in Beijing, China, Lepu Medical Technology is recognized as a leading player in China’s medical technology industry. Recent major changes include accelerated development and commercialization efforts in structural heart disease devices, including transcatheter aortic valve systems and mitral valve repair systems, alongside the advancement of neurostimulation systems and renal artery ablation catheters entering clinical trials. The company has focused on innovation through new product launches such as its AI-driven tablet patient monitor and iterations of digital health and hospital network management solutions. It has also adjusted its financial reporting standards and strengthened its product pipeline with bioresorbable coronary scaffolds and advanced cardiovascular artificial intelligence systems. Lepu continues to expand strategic efforts in global markets and enhance its capabilities in in vitro diagnostics and interventional products. These developments reflect its strategic priority on product innovation, healthcare service expansion, and international growth.